Moderna Therapeutics is working with Amazon’s cloud service, Amazon Web Services (AWS), to deliver a new class of medicines. The Cambridge, Massachusetts-based biotechnology company, has already undergone clinical trials with mRNA, molecules that convey genetic information from DNA to the ribosome, to develop personalized therapies for a wide range of diseases, including cancer, infectious diseases and rare liver diseases. Notably, the company has called mRNA and its drug development process “the software of life.”...
Sorry, you need to subscribe to read this article.
If you would like to access this article, please subscribe below.
Premium subscribers receive complete access to our site content which includes market research and insights as well as coverage of the most important news, issues and events related to the healthcare technology industry.